Rankings
▼
Calendar
OMER FY 2017 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena
OMER
Omeros Corporation
$821M
FY 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$65M
+55.8% YoY
Gross Profit
$64M
98.3% margin
Operating Income
-$44M
-67.7% margin
Net Income
-$53M
-82.5% margin
EPS (Diluted)
$-1.17
Cash Flow
Operating Cash Flow
-$36M
Free Cash Flow
-$37M
Stock-Based Comp.
$13M
Balance Sheet
Total Assets
$116M
Total Liabilities
$119M
Stockholders' Equity
-$3M
Cash & Equivalents
$3M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$65M
$42M
+55.8%
Gross Profit
$64M
$40M
+58.6%
Operating Income
-$44M
-$54M
+19.1%
Net Income
-$53M
-$67M
+19.9%
← Q4 2016
All Quarters
Q1 2017 →